(Q34519174)

2 August 2017

1 reference

title

Sublingual apomorphine for the treatment of erectile dysfunction (English)

1 reference

2 August 2017

1 reference

1

John P Mulhall

1 reference

2 August 2017

language of work or name

English

0 references

publication date

1 February 2002

1 reference

Expert Opinion on Investigational Drugs

2 August 2017

published in

1 reference

2 August 2017

volume

11

1 reference

2 August 2017

issue

2

1 reference

2 August 2017

page(s)

295-302

1 reference

Oral sildenafil in the treatment of erectile dysfunction. Sildenafil Study Group

2 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.2.295

Apomorphine: clinical studies on erectile impotence and yawning.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.2.295

Sexual behavior in male rats after radiofrequency or dopamine-depleting lesions in nucleus accumbens

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.2.295

Central neuropharmacological agents and mechanisms in erectile dysfunction: the role of dopamine

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.2.295

Dopaminergic neurotransmission at the paraventricular nucleus of hypothalamus in central regulation of penile erection in the rat

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.2.295

Dopamine agonists increase nitric oxide production in the paraventricular nucleus of the hypothalamus: correlation with penile erection and yawning

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.2.295

10.1517/13543784.11.2.295

21 January 2018

Identifiers

DOI

1 reference

2 August 2017

1 reference